References
- Garratty G. Drug-induced immune hemolytic anemia. In: Garratty G, ed. Immunobiology of transfusion medicine. New York: Marcel Dekker, 1993:523–51.
- Petz LD. Drug-induced immune hemolytic anemia. In: Nance SJ, ed. Immune destruction of red blood cells. Arlington, VA: American Association of Blood Banks, 1989:53–75.
- Mueller-Eckhardt C, Salama A. Drug-induced immune cytope- nias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites. Transfus Med Rev 1990;IV:69–77.
- Petz LD. Drug-induced autoimmune hemolytic anemia. Transfus Med Rev 1993;VII:242–54.
- Sokol RJ, Booker DJ, Stamps R. Investigation of patients with autoimmune hemolytic anemia and provision of blood for transfusion. J Clin Pathol 1995;48:602–10.
- Salama A, Mueller-Eckhardt C. The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. N Engl J Med 1985;313:469–74.
- Petz LD, Branch DR. Drug-induced immune hemolytic anemia. In: Chaplin H, ed. Immune hemolytic anemias. New York: Churchill Livingstone, 1985:47–94.
- Kramer MR, Levene C, Hershko C. Severe reversible autoimmune haemolytic anaemia and thrombocytopenia associated with diclofenac therapy. Scand J Haematol 1986;36:118–20.
- Lopez A, Linares M, Sánchez H, Blanquer A. Autoimmune hemolytic anemia induced by diclofenac. Ann Pharmacother 1995;29:787.
- Heuft HG, Postels H, Hoppe L, et al. Eine tödlich verlaufene immunhämolytische Anämie nach Applikation von Diclofenac. Beitr Infusionsther 1990;26:412–4.
- Johnson ST, Weitekamp LA, Wilkins JL, et al. Diclofenac-dependent antibody with relative e specificity causing hemolytic anemia and emphasizing the need for metabolite testing. Transfusion 1993;33(Suppl):63S.
- Salama A, Göttsche B, Mueller-Eckhardt C. Autoantibodies and drugs or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis. Br J Haematol 1991;77:546–9.